These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 33493008)
1. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion. Bhatt U; Malakar TK; Murty US; Banerjee S Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008 [TBL] [Abstract][Full Text] [Related]
2. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related]
3. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
4. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing. Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075 [TBL] [Abstract][Full Text] [Related]
5. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing. Zhang P; Xu P; Chung S; Bandari S; Repka MA Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460 [TBL] [Abstract][Full Text] [Related]
6. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
7. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance. Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet. Nyavanandi D; Mandati P; Narala S; Alzahrani A; Kolimi P; Pradhan A; Bandari S; Repka MA Int J Pharm; 2022 Nov; 628():122283. PubMed ID: 36244563 [TBL] [Abstract][Full Text] [Related]
9. 3D printed tinidazole tablets coupled with melt-extrusion techniques for formulating child friendly medicines. Pawar A; Karanwad T; Banerjee S Eur J Pharm Biopharm; 2024 Oct; 203():114471. PubMed ID: 39186960 [TBL] [Abstract][Full Text] [Related]
10. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
11. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance. Bandari S; Nyavanandi D; Dumpa N; Repka MA Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550 [TBL] [Abstract][Full Text] [Related]
12. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production. Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253 [TBL] [Abstract][Full Text] [Related]
13. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related]
14. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Zhang J; Feng X; Patil H; Tiwari RV; Repka MA Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768 [TBL] [Abstract][Full Text] [Related]
15. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages. Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916 [TBL] [Abstract][Full Text] [Related]
16. Development of 3D-printed dual-release fixed-dose combination through double-melt extrusion. Oh HS; Park JB Int J Pharm; 2024 Aug; 661():124407. PubMed ID: 38955239 [TBL] [Abstract][Full Text] [Related]
17. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing. Gültekin HE; Tort S; Acartürk F Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313 [TBL] [Abstract][Full Text] [Related]
18. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing. Chung S; Zhang P; Repka MA Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727 [TBL] [Abstract][Full Text] [Related]
19. Screening of pharmaceutical polymers for extrusion-Based Additive Manufacturing of patient-tailored tablets. Samaro A; Janssens P; Vanhoorne V; Van Renterghem J; Eeckhout M; Cardon L; De Beer T; Vervaet C Int J Pharm; 2020 Aug; 586():119591. PubMed ID: 32640268 [TBL] [Abstract][Full Text] [Related]
20. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing. Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]